Cargando…
Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice
The emergence of new immune-evasive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and subvariants outpaces the development of vaccines specific against the dominant circulating strains. In terms of the only accepted immune correlate of protection, the inactivated whole-virion...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052291/ https://www.ncbi.nlm.nih.gov/pubmed/36992395 http://dx.doi.org/10.3390/v15030687 |
_version_ | 1785015126213001216 |
---|---|
author | Cai, Jian-Piao Luo, Cuiting Wang, Kun Cao, Hehe Chen, Lin-Lei Zhang, Xiaojuan Han, Yuting Yin, Feifei Zhang, Anna Jinxia Chu, Hin Yuan, Shuofeng Kok, Kin-Hang To, Kelvin Kai-Wang Chen, Honglin Chen, Zhiwei Jin, Dong-Yan Yuen, Kwok-Yung Chan, Jasper Fuk-Woo |
author_facet | Cai, Jian-Piao Luo, Cuiting Wang, Kun Cao, Hehe Chen, Lin-Lei Zhang, Xiaojuan Han, Yuting Yin, Feifei Zhang, Anna Jinxia Chu, Hin Yuan, Shuofeng Kok, Kin-Hang To, Kelvin Kai-Wang Chen, Honglin Chen, Zhiwei Jin, Dong-Yan Yuen, Kwok-Yung Chan, Jasper Fuk-Woo |
author_sort | Cai, Jian-Piao |
collection | PubMed |
description | The emergence of new immune-evasive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and subvariants outpaces the development of vaccines specific against the dominant circulating strains. In terms of the only accepted immune correlate of protection, the inactivated whole-virion vaccine using wild-type SARS-CoV-2 spike induces a much lower serum neutralizing antibody titre against the Omicron subvariants. Since the inactivated vaccine given intramuscularly is one of the most commonly used coronavirus disease 2019 (COVID-19) vaccines in developing regions, we tested the hypothesis that intranasal boosting after intramuscular priming would provide a broader level of protection. Here, we showed that one or two intranasal boosts with the Fc-linked trimeric spike receptor-binding domain from wild-type SARS-CoV-2 can induce significantly higher serum neutralizing antibodies against wild-type SARS-CoV-2 and the Omicron subvariants, including BA.5.2 and XBB.1, with a lower titre in the bronchoalveolar lavage of vaccinated Balb/c mice than vaccination with four intramuscular doses of inactivated whole virion vaccine. The intranasally vaccinated K18-hACE2-transgenic mice also had a significantly lower nasal turbinate viral load, suggesting a better protection of the upper airway, which is the predilected site of infection by Omicron subvariants. This intramuscular priming and intranasal boosting approach that achieves broader cross-protection against Omicron variants and subvariants may lengthen the interval required for changing the vaccine immunogen from months to years. |
format | Online Article Text |
id | pubmed-10052291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100522912023-03-30 Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice Cai, Jian-Piao Luo, Cuiting Wang, Kun Cao, Hehe Chen, Lin-Lei Zhang, Xiaojuan Han, Yuting Yin, Feifei Zhang, Anna Jinxia Chu, Hin Yuan, Shuofeng Kok, Kin-Hang To, Kelvin Kai-Wang Chen, Honglin Chen, Zhiwei Jin, Dong-Yan Yuen, Kwok-Yung Chan, Jasper Fuk-Woo Viruses Article The emergence of new immune-evasive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and subvariants outpaces the development of vaccines specific against the dominant circulating strains. In terms of the only accepted immune correlate of protection, the inactivated whole-virion vaccine using wild-type SARS-CoV-2 spike induces a much lower serum neutralizing antibody titre against the Omicron subvariants. Since the inactivated vaccine given intramuscularly is one of the most commonly used coronavirus disease 2019 (COVID-19) vaccines in developing regions, we tested the hypothesis that intranasal boosting after intramuscular priming would provide a broader level of protection. Here, we showed that one or two intranasal boosts with the Fc-linked trimeric spike receptor-binding domain from wild-type SARS-CoV-2 can induce significantly higher serum neutralizing antibodies against wild-type SARS-CoV-2 and the Omicron subvariants, including BA.5.2 and XBB.1, with a lower titre in the bronchoalveolar lavage of vaccinated Balb/c mice than vaccination with four intramuscular doses of inactivated whole virion vaccine. The intranasally vaccinated K18-hACE2-transgenic mice also had a significantly lower nasal turbinate viral load, suggesting a better protection of the upper airway, which is the predilected site of infection by Omicron subvariants. This intramuscular priming and intranasal boosting approach that achieves broader cross-protection against Omicron variants and subvariants may lengthen the interval required for changing the vaccine immunogen from months to years. MDPI 2023-03-06 /pmc/articles/PMC10052291/ /pubmed/36992395 http://dx.doi.org/10.3390/v15030687 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cai, Jian-Piao Luo, Cuiting Wang, Kun Cao, Hehe Chen, Lin-Lei Zhang, Xiaojuan Han, Yuting Yin, Feifei Zhang, Anna Jinxia Chu, Hin Yuan, Shuofeng Kok, Kin-Hang To, Kelvin Kai-Wang Chen, Honglin Chen, Zhiwei Jin, Dong-Yan Yuen, Kwok-Yung Chan, Jasper Fuk-Woo Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice |
title | Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice |
title_full | Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice |
title_fullStr | Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice |
title_full_unstemmed | Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice |
title_short | Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice |
title_sort | intranasal boosting with spike fc-rbd of wild-type sars-cov-2 induces neutralizing antibodies against omicron subvariants and reduces viral load in the nasal turbinate of mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052291/ https://www.ncbi.nlm.nih.gov/pubmed/36992395 http://dx.doi.org/10.3390/v15030687 |
work_keys_str_mv | AT caijianpiao intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT luocuiting intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT wangkun intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT caohehe intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT chenlinlei intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT zhangxiaojuan intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT hanyuting intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT yinfeifei intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT zhangannajinxia intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT chuhin intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT yuanshuofeng intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT kokkinhang intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT tokelvinkaiwang intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT chenhonglin intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT chenzhiwei intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT jindongyan intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT yuenkwokyung intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice AT chanjasperfukwoo intranasalboostingwithspikefcrbdofwildtypesarscov2inducesneutralizingantibodiesagainstomicronsubvariantsandreducesviralloadinthenasalturbinateofmice |